Monopar Therapeutics

MNPR

Monopar Therapeutics has been a target of short sellers for a while. The current short interest of 16.81% is roughly at the average of the last 12 months (18.57%).

Short Interest Trend

Share Price

Total NSP

16.81%

+0.63%

vs. last month

Also interesting? All insider buys at Monopar Therapeutics

Found an error? Questions? Ideas?